Newer quinolone antibiotics (levofloxacin, moxifloxacin) have good activity against respiratory tract pathogens. However, because of their broad spectrum and potential for promoting increased resistance, these agents should be reserved for patients who have failed antibiotic therapy.
Bugs & Drugs® is the recommended reference for treatment of infectious diseases and appropriate antimicrobial use. It is peer-reviewed, evidence-based, and frequently updated. Bugs & Drugs® is supported by the Do Bugs Need Drugs? ® community-education program, and is funded by the Health Ministries of the provinces of Alberta and British Columbia. To access it, please use the following links.
Alberta:
- AHS staff & physicians with an AHS computer: Bugs & Drugs® (AHS)
- For Albertans without an institutional affiliation: Bugs & Drugs®
- To access through Netcare, please log in and go to Clinical eTOOLS.
British Columbia:
Using the web version in both Alberta and British Columbia requires an ISP address located within the province.